Sustained weight loss with semaglutide once weekly in patients without type 2 diabetes and post-bariatric treatment failure.

Lautenbach, Anne; Kantowski, Tobias; Wagner, Jonas; Mann, Oliver; Stoll, Fabian; Aberle, Jens

Lautenbach, Anne; Kantowski, Tobias; Wagner, Jonas; Mann, Oliver; Stoll, Fabian; Aberle, Jens.

Afiliación

Lautenbach A; III Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Kantowski T; III Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Wagner J; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Mann O; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Stoll F; III Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Aberle J; III Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Clin Obes ; 13(5): e12593, 2023 Oct.

Article en En | MEDLINE | ID: mdl-37364260

Asunto(s)

Bariatria; Diabetes Mellitus Tipo 2; Humanos; Diabetes Mellitus Tipo 2/tratamiento farmacológico; Hipoglucemiantes/uso terapéutico; Estudios Retrospectivos; Pérdida de Peso; Insuficiencia del Tratamiento

Palabras clave

GLP-1 receptor agonist; bariatric surgery; semaglutide; treatment failure; weight regain

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Bariatria / Diabetes Mellitus Tipo 2 Tipo de estudio: Observational_studies Idioma: En Revista: Clin Obes Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google